Friday, November 22, 2019
Print Current Day:
|
|
SESSION 71 SCHEDULE | |
Friday
SESSION 71:
NEW DEVELOPMENTS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH TEVAR AND THE TREATMENT OF TAAAs (5-MINUTE TALKS)
|
|
x | |
6:40 AM - 6:45 AM | Animal Studies Show 2 Separate Different Mechanisms Contribute To Spinal Cord Ischemia (SCI) After TAAA Repairs: What Are Their Therapeutic Implications Clinically |
Presenter(s):Hamdy Awad, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:46 AM - 6:51 AM | SCI In The Physician-Sponsored IDEs For F/BEVAR To Treat Complex AAA And TAAAs: Incidence, Optimal Prevention Techniques And Lessons Learned |
Presenter(s):Adam Beck, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:52 AM - 6:57 AM | Maintaining Euglycemia During Endovascular TAAA Repairs Seems To Decrease The Incidence And Severity Of SCI: What Is The Evidence And What Is The Mechanism |
Presenter(s):Jade S. Hiramoto, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
6:58 AM - 7:03 AM | Update On Minimally Invasive Intercostal Segmental Artery Coil Embolization (MIS2ACE) To Produce Ischemic Preconditioning To Prevent SCI With TAAA Repair: Clinical Experience And Status Of The PAPA-ARTIS RCT |
Presenter(s):Christian D. Etz, MD, PhD / Daniela Branzan, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:04 AM - 7:09 AM | Oversized EMBO Aortic Stent-Graft To Occlude The Origins Of Intercostal Arteries To Produce Ischemic Preconditioning Of The Spinal Cord Prior To TAAA Repair And Prevent SCI: How Does It Work And Updated Experience |
Presenter(s):Bjõrn Sonesson, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:10 AM - 7:15 AM | How Can Cerebrospinal (CSF) Fluid Analysis Help In The Management Of SCI After TAAA Repair: Can It Indicate Prognosis |
Presenter(s):Bijan Modarai, PhD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:16 AM - 7:21 AM | CSF Drainage Is Not Benign: What Are Its Complications And How To Minimize Paraplegia Without CSF Drainage During TAAA Repair |
Presenter(s):Michel J. Bosiers, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:22 AM - 7:27 AM | What Is New In The Prevention Of SCI During Open And Endo TAAA Repairs: When CSF Drainage: When Not And How To Make It Safe |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:28 AM - 7:33 AM | Preoperative Spinal Drain Placement Does Prevent SCI In Endovascular TAAA And Thoracic Aneurysm Repairs Based On The Results Of A Larger Multicenter Propensity Matched Analysis |
Presenter(s):James H. Black III, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:34 AM - 7:39 AM | Determinants Of SCI Risk In TAAA Repairs: How It Can Best Be Managed: Value Of Motor Evoked Potential Monitoring |
Presenter(s):Michael J. Jacobs, MD / Geert Willem H. Schurink, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:40 AM - 7:45 AM | Value Of Near Infrared Spectrometry (NIRS) Monitoring Of Spinal Muscles Oxygenation To Reflect SCI During TAAA Repairs: How It Works And Updated Experience |
Presenter(s):Christian D. Etz, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:46 AM - 7:51 AM | Progress In Preventing SCI During Endo TAAA Repairs: Value Of NIRS Monitoring To Guide Temporary Sac Perfusion And Staging: Complications Of Spinal Fluid Drainage And How To Minimize Them |
Presenter(s):Gustavo S. Oderich, MD, FACS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
7:52 AM - 8:00 AM | Panel Discussion |
END OF SESSION 71 | |
SESSION 72 SCHEDULE | |
Friday
SESSION 72:
ADVANCES IN THE TREATMENT OF CAROTID STENOSIS: MESH COVERED STENTS FOR CAROTID ARTERY STENTING (CAS) AND UPDATE ON TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION (TCAR) FOR CAS
|
|
x | |
NEW DEVELOPMENTS IN MESH COVERED STENTS | |
8:05 AM - 7:59 AM | Update On The 3 Mesh Covered Stents For CAS: What Are The Differences Between Them And Overview Of What Is The Status Of Their Safety And Efficacy |
Presenter(s):Max Amor, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:06 AM - 8:11 AM | Update On The C-Guard Micronet Mesh Covered Stent For CAS: Longer Term Results: Advantages And Are There Late Downsides Like ISR Or Late Thrombosis |
Presenter(s):Piotr Musialek, MD, DPhil Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:12 AM - 8:17 AM | Value And Limitations Of Mesh Covered Stents For CAS In Symptomatic And Asymptomatic Patients: 6-Year Results: Are ISR And Thrombotic Occlusions A Problem: Technical Tips To Optimize Their Use |
Presenter(s):Stefan Mueller-Huelsbeck, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:18 AM - 8:23 AM | Randomized Controlled Trial (RCT) Of CAS With C-Guard Mesh Covered Stent Versus Wallstent: Is There A Difference In Perioperative Strokes Or DW-MRI Brain Lesions Up To 12 Months: The IRON-GUARD Study |
Presenter(s):Laura Capoccia, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:24 AM - 8:29 AM | What Value Will Mesh Covered Stents Have In Improving CAS Outcomes: Is There A Downside |
Presenter(s):L. Nelson Hopkins, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:30 AM - 8:35 AM | Panel Discussion |
TCAR RELATED TOPICS | |
8:36 AM - 8:41 AM | ROADSTER 2 Trial Shows Low Stroke Risk With TCAR (Silk Road Medical) Even With Inexperienced Operators And In High Risk Patients With High Risk Lesions |
Presenter(s):Vikram S. Kashyap, MD / Christopher J. Kwolek, MD, MBA / Peter A. Schneider, MD / Richard P. Cambria, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:42 AM - 8:47 AM | TCAR Outcomes Compare Favorably With Those Of CEA Even In Symptomatic Medically High Risk Patients: A Propensity Matched Study Of 5160 Patients From The SVS VQI Registry |
Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:48 AM - 8:53 AM | DEBATE: TCAR Is Not Safer Than Transfemoral CAS: Based On Results From A Multicenter Registry |
Presenter(s):Thomas G. Brott, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
8:54 AM - 8:59 AM | DEBATE: Not So: TCAR Is Safer Than Transfemoral CAS Especially In Older (> 77) High Risk Patients With High Risk Lesions: TCAR Should Be The Standard Of Care For Invasive Treatment |
Presenter(s):Mahmoud B. Malas, MD, MHS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:00 AM - 9:05 AM | DEBATE: Not So: In Experienced Hands And With Appropriate Precautions Transfemoral CAS Will Be The Best Invasive Treatment For Most Patients |
Presenter(s):Giancarlo Biamino, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:06 AM - 9:11 AM | Why TCAR Should Replace Transfemoral CAS And Why It Won’t |
Presenter(s):Venkatesh G. Ramaiah, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:12 AM - 9:17 AM | DEBATE: Why TCAR Should Replace CEA And Transfemoral CAS For Carotid Stenosis Patients Justifiably Requiring Invasive Treatment |
Presenter(s):Wesley S. Moore, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:18 AM - 9:23 AM | DEBATE: Not So: Why CEA Should Remain The Standard Of Care For Carotid Stenosis Patients Requiring Invasive Treatments |
Presenter(s):Ross Naylor, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:24 AM - 9:32 AM | Panel Discussion |
9:32 AM - 9:42 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 72 | |
SESSION 73 SCHEDULE | |
Friday
SESSION 73:
MORE CAROTID RELATED TOPICS: MORE ON TCAR; BEST MEDICAL TREATMENT (BMT) FOR CAROTID DISEASE AND BMT'S IMPACT ON INVASIVE TREATMENTS; THE EFFECT OF CAROTID DISEASE AND ITS TREATMENT ON COGNITION
|
|
x | |
9:42 AM - 9:47 AM | Technical Tips For Optimal Performance Of TCAR: Pitfalls Of And Contraindications To TCAR |
Presenter(s):Vikram S. Kashyap, MD / Richard P. Cambria, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:48 AM - 9:53 AM | Favorable TCAR Results In Patients Over 80 |
Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
9:54 AM - 9:59 AM | Cost Comparison Of TCAR, CEA And Transfemoral CAS |
Presenter(s):Richard J. Powell, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
MEDICAL TREATMENTS RELATED TO CAROTID STENOSIS | |
10:00 AM - 10:05 AM | Good Medical Treatment (With PCSK-9 Inhibitors) Can Control And Shrink Carotid Plaques: How Low Should The LDL-C Be Pushed: Will Patients Really Needing CAS Or CEA Vanish |
Presenter(s):Thomas G. Brott, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:06 AM - 10:11 AM | What Is Best Medical Treatment For Patients And Arteries With Carotid Stenosis: How To Render Most Plaques Harmless: Value Of Statins, Ezetimibe And Diet; Optimal LDL-C Level To Strive For |
Presenter(s):J. David Spence, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
CAROTID STENOSIS AND COGNITION | |
10:12 AM - 10:17 AM | Asymptomatic Carotid Stenosis (ACS) Is Associated With Cognitive Dysfunction, Impaired Mobility And Increased Fall Rates: Is There Any Evidence That CEA Or CAS Will Improve These Impairments: Will CREST 2 Provide Answers |
Presenter(s):Brajesh K. Lal, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:18 AM - 10:23 AM | Does CEA For ACS Prevent Dementia 10-25 Years Later: Findings From The ACST RCT |
Presenter(s):Alison Halliday, MS, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:24 AM - 10:31 AM | Panel Discussion |
END OF SESSION 73 | |
SESSION 74 SCHEDULE | |
Friday
SESSION 74:
MORE CAROTID RELATED TOPICS: CONTROVERSIES OVER INVASIVE TREATMENTS OF ASYMPTOMATIC PATIENTS WITH CAROTID STENOSIS (ACS) AND OPTIMAL TIMING OF INVASIVE CAROTID TREATMENTS AFTER SYMPTOM ONSET
|
|
x | |
TREATMENT OF ACS – A MEGA-DEBATE | |
10:31 AM - 10:36 AM | DEBATE: What % Of Patients With ACS Need Invasive Treatment With CEA Or CAS: 0% - Such Treatment Causes More Harm Than Providing Benefit |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:37 AM - 10:42 AM | DEBATE: Which Patients With ACS Can Justifiably Be Treated Invasively: It Is A Small Percentage (< 5%): How Can They Be Identified |
Presenter(s):J. David Spence, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:43 AM - 10:48 AM | DEBATE: The Low Stroke Risk (~1% Per Year) In Patients With Severe ACS Prior To Intervention Or Only Treated Medically In A Large Health Care System Study (3855 Patients) Indicates That CEA And CAS Cannot Do Better |
Presenter(s):Robert W. Chang, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:49 AM - 10:54 AM | DEBATE: The Case For Treating ~20% Of High Grade ACS Patients With CEA, TCAR Or CAS: How Can They Be Identified |
Presenter(s):Richard P. Cambria, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
10:55 AM - 11:00 AM | DEBATE: The Case For Treating >20% Of Patients With High Grade ACS Invasively By CEA, TCAR Or CAS: How Can They Be Selected |
Presenter(s):Peter A. Schneider, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:01 AM - 11:06 AM | Panel Discussion |
OPTIMAL TIMING OF CEA AND CAS AFTER SYMPTOM ONSET | |
11:06 AM - 11:11 AM | In Stroke Patients With A Large Cerebral Infarct On CT From Carotid Stenosis, CEA Should Be Performed But Only After A Delay Of 4-6 Weeks |
Presenter(s):Gianluca Faggioli, MD / Mauro Gargiulo, MD / Andrea Stella, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:12 AM - 11:17 AM | Optimal Timing Of CEA After A TIA Or Small Stroke: Why Is It Controversial And What Delay Is Best Under Varying Circumstances |
Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:18 AM - 11:23 AM | DEBATE: Optimal Timing For CEA After A TIA Or Small Stroke Is 7-14 Days: But CAS Is Unsafe Within That Window |
Presenter(s):Ross Naylor, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:24 AM - 11:29 AM | DEBATE: Not So: If Done Right, CAS Is Equally Safe Within That 7-14-Day Window: Technical Precautions |
Presenter(s):Klaus D. Mathias, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:30 AM - 11:35 AM | CEA For A TIA Or Small Stroke Is Safely Performed 2-5 Days After The Event, Not So For CAS: When Is CAS Equally Safe Based On A Large German Registry Study |
Presenter(s):Hans-Henning Eckstein, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:36 AM - 11:41 AM | DEBATE: CEA Is Relatively Safe Within 48 Hours After A TIA Or Minor Stroke: What Precautions Are Necessary |
Presenter(s):R. Clement Darling III, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:42 AM - 11:47 AM | DEBATE: Not So: CEA Within 48 Hours Of Stroke Symptom Onset Has High Risks: After 48 Hours The Risk Between 3-14 Days Is The Same As After 14 Days: So Optimal Time For CEA Is 3-14 Days After Symptom Onset |
Presenter(s):Peter Gloviczki, MD / Thomas C. Bower, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:48 AM - 11:53 AM | The Value Of Early CEA Within 7 Days Of The Index TIA Or Small Stroke Is Neutralized By Aggressive Treatment With High Dose Statins |
Presenter(s):Gert J. de Borst, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
11:54 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 74 | |
SESSION 75 SCHEDULE | |
Friday
SESSION 75:
NEW DEVELOPMENTS IN THE CAS VERSUS CEA CONTROVERSY; NEED FOR CEA/CAS WITH OTHER SURGERY; AND OTHER UNUSUAL BUT IMPORTANT CAROTID RELATED TOPICS AND A HISTORICAL NOTE ON CAS
Location: Grand Ballroom East, 3rd Floor
Moderators:Keith D. Calligaro, MD / Hans-Henning Eckstein, MD, PhD |
|
x | |
1:00 PM - 1:05 PM | DEBATE: CEA Is Currently Superior To CAS, But The Paradigm Could Shift And Why |
Presenter(s):J. David Spence, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:06 PM - 1:11 PM | DEBATE: Not So: The Paradigm Has Already Shifted: CAS Is Better Than CEA – Especially In Patients <70 Years Of Age: What Are Future Expectations |
Presenter(s):D. Christopher Metzger, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:12 PM - 1:17 PM | CAS Versus CEA: Why The Debate Will Never End: Bias Overwhelms Facts And Logic |
Presenter(s):Carlo Setacci, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | CEA Or CAS Are Rarely If Ever Justified For ACS In Patients About To Undergo A Coronary Artery Bypass, Coronary Stenting Or Other Major Surgery: What Is The Evidence |
Presenter(s):Ross Naylor, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:24 PM - 1:29 PM | How To Decide The Timing Of Intervention After An Acute Carotid Lesion Related Stroke: Role Of Telemedicine: What Imaging Helps: How To Decide CEA Versus CAS |
Presenter(s):Hernan A. Bazan, MD, FACS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | Value And Limitations Of Intraoperative Duplex Scanning During CEA And Value Of Gore Hybrid (Partially Stented) Graft For Bailout Of Difficult Technical Problems During CEA |
Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:36 PM - 1:41 PM | Carotid Webs Are A Cause Of Serious Strokes: How To Diagnose And Treat Them |
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:42 PM - 1:47 PM | Concomitant CEA And Carotid-Subclavian Bypass Indications, Technical Tips And Results: Based On A 40-Year Experience |
Presenter(s):Ali F. AbuRahma, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
1:48 PM - 1:53 PM | Surveillance Is Rarely Needed After CEA And CAS Because Reintervention Is Rarely Needed: When Is Surveillance Justified |
Presenter(s):Ross Naylor, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
AN HISTORICAL NOTE | |
1:54 PM - 1:59 PM | 40 Years Of CAS: A Pioneer’s Look Back |
Presenter(s):Klaus D. Mathias, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:00 PM - 2:07 PM | Panel Discussion |
END OF SESSION 75 | |
SESSION 76 SCHEDULE | |
Friday
SESSION 76:
UPDATES ON THE COMPLETED AND ONGOING CAROTID RCTs AND THEIR PITFALLS; NEED FOR POST CEA/CAS SURVEILLANCE; IMPLICATIONS OF FILTER DEBRIS
|
|
x | |
2:07 PM - 2:12 PM | Pooled Analysis Of ACT 1 And CREST In Asymptomatic Carotid Stenosis (ACS) Patients Under 80 Years Of Age: How It Can Help In Decision Making |
Presenter(s):Jon S. Matsumura, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:13 PM - 2:18 PM | Stroke And TIA Rates After 1 Year In SPACE 2: A Stopped RCT Comparing CEA Versus CAS Versus Best Medical Treatment In ACS Patients: What Hint Do They Give Us |
Presenter(s):Hans-Henning Eckstein, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:19 PM - 2:24 PM | DEBATE: Update On Progress In CREST 2: It Will Produce Valuable Results, Conclusions And Answers: Interesting Findings To Date |
Presenter(s):Brajesh K. Lal, MD / Thomas G. Brott, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:25 PM - 2:30 PM | DEBATE: Not So: A Skeptic’s View: Why CREST 2, A Good RCT, May Produce Interesting Information But Will Not Answer Key Questions Or Settle Existing Controversy |
Presenter(s):Anne L. Abbott, MD, PhD, FRACP Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:31 PM - 2:36 PM | What Impact Will CREST 2 Have On CEA And CAS And The Controversy Surrounding The Treatment Of Patients With ACS: Predictions For The Future Of Carotid Treatment - Invasive And Otherwise |
Presenter(s):L. Nelson Hopkins, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:37 PM - 2:42 PM | Current Status Of ECST 2: What Is This RCT Comparing: What Will It Tell Us And What Is Its Progress |
Presenter(s):Richard Bulbulia, MA MD FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:43 PM - 2:48 PM | Update On ACST 2: When Will This RCT Complete Recruitment: What Has It Told Us Thus Far: What Are Its Limitations |
Presenter(s):Alison Halliday, MS, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:49 PM - 2:54 PM | Pitfalls And Limitations Of The Esteemed And Often Quoted CAS Versus CEA RCTs: Why They May Be Misleading |
Presenter(s):Ali F. AbuRahma, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
2:55 PM - 3:00 PM | Addition To CEA Of A Proximal Intervention (To Common Carotid Or Innominate Arteries) Increases The Risk Of Stroke Or Death: From SVS VQI Data |
Presenter(s):Mark Conrad, MD, MMSc Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:01 PM - 3:06 PM | Qualitative Analysis Of Embolic Debris Caught In Different Filters During CAS: What Is Their Nature And What Are The Implications |
Presenter(s):Franco Grego, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:07 PM - 3:14 PM | Panel Discussion |
3:14 PM - 3:24 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 76 | |
SESSION 77 SCHEDULE | |
Friday
SESSION 77:
A CAROTID CONTROVERSY AND MORE CAROTID UPDATES; OTHER HOT NEW OR UPDATED TOPICS
Location: Grand Ballroom East, 3rd Floor
Moderators:Mark A. Adelman, MD / Caron B. Rockman, MD / Gregg S. Landis, MD |
|
x | |
CAROTID RELATED TOPICS | |
3:24 PM - 3:29 PM | Carotid Body Tumors: Recent Advances In Treatments; Importance Of Adjunctive Measures And Endovascular Aids In Advanced Cases |
Presenter(s):Martin Bjorck, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:30 PM - 3:35 PM | DEBATE: CAS Is The Best Treatment For Carotid Pseudo-Occlusions Or String Sign: When And When Not To Treat |
Presenter(s):Sonia Ronchey, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:36 PM - 3:41 PM | DEBATE: Not So: No Intervention Or CEA Are The Best Treatments For A Carotid String Sign: When Is Each Best |
Presenter(s):Ross Naylor, MD, FRCS Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:42 PM - 3:47 PM | Update On The Value And Safety Of Protamine Use In CEA: It Should Be Used, How And Precautions: From The New England VQI |
Presenter(s):David H. Stone, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:48 PM - 3:53 PM | Why Duplex Findings Can Be Misleading For Carotid And Lower Extremity Lesions: When Should Treatment Decisions Not Be Based Solely On Them |
Presenter(s):Ido Weinberg, MD, MSc Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
3:54 PM - 3:59 PM | CEA In Patients With Neck Irradiation Has No Higher Risks Of Stroke, Death Or MI Than Standard CEA: What Are The Technical Challenges And When Should CAS Or Medical Treatment Be Preferred |
Presenter(s):Mark Conrad, MD, MMSc Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:00 PM - 4:05 PM | PTFE Grafts Work As Well Long-Term As Vein Grafts For Carotid Reconstructions After Carotid Degenerative Aneurysm Excision |
Presenter(s):Jean-Baptiste Ricco, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:06 PM - 4:12 PM | Panel Discussion |
OTHER EXCITING TOPICS AND UPDATES | |
4:12 PM - 4:17 PM | The Real Origin Of The Flow Reversal Concept For Cerebral Protection During CAS |
Presenter(s):Juan C. Parodi, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:18 PM - 4:23 PM | Update On Endovascular Treatment Of Erectile Dysfunction: Diagnosis, Indications, Techniques And Results |
Presenter(s):Nicolas A. Diehm, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:24 PM - 4:29 PM | Difference In Cancer Rates After Open AAA Repair And EVAR: What Are The Reasons For These Differences |
Presenter(s):Matt M. Thompson, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:30 PM - 4:35 PM | Can Oral Anticoagulation Treatment With TBADs Promote Remodeling And Healing; What Is The Evidence And Possible Mechanisms |
Presenter(s):Mario L. Lachat, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:36 PM - 4:42 PM | Panel Discussion |
END OF SESSION 77 | |
SESSION 78 SCHEDULE | |
Friday
SESSION 78:
PERCUTANEOUS CLOSURE DEVICES: NEW DEVELOPMENTS IN ESTABLISHED DEVICES AND NEW DEVICES; ADVANCES IN WOUND CARE
Location: Grand Ballroom East, 3rd Floor
Moderators:Zvonimir Krajcer, MD, FACC / Gregg S. Landis, MD |
|
x | |
CLOSURE DEVICES | |
4:42 PM - 4:47 PM | Update On Perclose And Proglide Devices For Large Sheath Access Site Closure; Why They Are Better Than Open Closure And Hard To Beat: What Is The Early Bird Sheath Technology (From Saranas) To Detect Access Site Bleeding |
Presenter(s):Zvonimir Krajcer, MD, FACC Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:48 PM - 4:53 PM | Facial Closure Of Large Sheath Percutaneous Access Has Its Limitations: Open Surgical Access Is Better |
Presenter(s):Nikolaos Tsilimparis, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
4:54 PM - 4:59 PM | Fancy And Unusual Methods To Overcome Disadvantaged Routine Access For EVAR, TEVAR And TAVR: Direct Aortic Sheath Placement, Transcaval Access, External And Endo Conduits, And More |
Presenter(s):Jeffrey P. Carpenter, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:00 PM - 5:05 PM | Next Generation Access Site Closure Devices: Manta, Per Q Seal, In Seal, Cross-Stitch, And NXT: How Do They Work: How Good Will They Be: Advantages And Limitations |
Presenter(s):Zvonimir Krajcer, MD, FACC Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:06 PM - 5:12 PM | Panel Discussion |
ADVANCES IN WOUND CARE | |
5:12 PM - 5:17 PM | Good And Durable Results Of Negative Pressure Non-Graft-Excisional Wound Care Treatment Of Prosthetic Arterial Graft Infection: It Is A Game Changer But Excision Of Infected Tissue Is Still Required |
Presenter(s):Zoran Rancic, MD, PhD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:18 PM - 5:23 PM | Rectus Femoris Muscle Flap For Non-Healing Groin Wounds With Arterial Grafts: It Is Better Than A Sartorius Flap: It Is Easy And How To Do It |
Presenter(s):Jan-Willem Elshof, MD Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:24 PM - 5:29 PM | Value Of Hyperbaric Oxygen In Vascular Patients With Wounds: Is It Real Or A Hoax: What Is The Evidence |
Presenter(s):Wayne J. Caputo, DPM Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:30 PM - 5:35 PM | Another View Of Hyperbaric O2: What Is The Evidence That It Improves Wound Healing Or Does It Just Provide Good Wound Care |
Presenter(s):Robert B. McLafferty, MD, MBA Location: Grand Ballroom East, 3rd Floor |
|
View Slides in PDF | |
5:36 PM - 5:42 PM | Panel Discussion End of Program J |
END OF SESSION 78 | |
SESSION 79 SCHEDULE | |
Friday
SESSION 79:
NEW DEVELOPMENTS IN POPLITEAL DISEASES AND THEIR TREATMENT: POPLITEAL ANEURYSMS, NON-ATHEROMATOUS DISEASES AND ENTRAPMENT SYNDROMES; VALUE OF DUPLEX AND OTHER IMAGING IN THEIR DIAGNOSIS
|
|
x | |
PROGRESS IN THE TREATMENT OF POPLITEAL ANEURYSMS | |
7:00 AM - 7:05 AM | With Thrombosed Popliteal Aneurysms Producing Acute Limb Ischemia Aspiration Vacuum Assisted Thrombectomy With The Indigo Device Works: Technical Tips And Results |
Presenter(s):Frank R. Arko, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:06 AM - 7:11 AM | Treatment Of A Giant Popliteal Aneurysm In A Patient With Loeys-Dietz Connective Tissue Disorder |
Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:12 AM - 7:17 AM | Endovascular Versus Open Treatment For Popliteal Aneurysms: When Is Each Best And Why |
Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:18 AM - 7:23 AM | DEBATE: Open Surgical Repair Of Popliteal Aneurysms Yields Better Results Than Stent-Graft Endo Repair In A Large Case Matched Swedish Study: The Differences Are Not Due To Tortuosity, Outflow Arteries Or Other Anatomic Variables |
Presenter(s):Martin Bjorck, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:24 AM - 7:29 AM | DEBATE: New Developments In Stent Graft Treatment Make Me Disagree: Endovascular Treatment Is Better In Many Cases: When Is It Not |
Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
NEW DEVELOPMENTS IN POPLITEAL ENTRAPMENTS | |
7:30 AM - 7:35 AM | Progress In The Treatment Of Popliteal Entrapment Syndromes: An Algorithm To Help With Successful Treatment |
Presenter(s):Niten Singh, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:36 AM - 7:41 AM | Functional Popliteal Entrapment Syndromes: What Is Their Pathogenesis: How To Diagnose Them With Modern Imaging: How Best To Treat Them |
Presenter(s):Katherine A. Gallagher, MD / Thomas W. Wakefield, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:42 AM - 7:47 AM | Non-Atherosclerotic Popliteal Artery Occlusive Disease: What Can It Be Due To And What Is The Best Treatment |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:48 AM - 7:53 AM | Duplex Findings In Non-Atherosclerotic Popliteal Artery Occlusive Disease: What Other Imaging May Be Needed |
Presenter(s):Michael R. Jaff, DO Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
7:54 AM - 8:02 AM | Panel Discussion |
END OF SESSION 79 | |
SESSION 80 SCHEDULE | |
Friday
SESSION 80:
NEW DEVELOPMENTS AND CONTROVERSIES IN THE OPTIMAL TREATMENT FOR INFECTED ARTERIES, AAAs, ARTERIAL GRAFTS AND ENDOGRAFTS
|
|
x | |
MYCOTIC INFECTED ANEURYSMS | |
8:02 AM - 8:07 AM | Mycotic Peripheral Arterial Aneurysms: Etiology And Best Current Treatment: When And How To Revascularize And When Not To |
Presenter(s):Mohammad H. Eslami, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:08 AM - 8:13 AM | How Valuable Is EVAR For The Treatment Of Mycotic AAAs: When Does It Work: Technical Tips And When Will It Not Work |
Presenter(s):Fred A. Weaver, MD, MMM Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:14 AM - 8:19 AM | For Mycotic AAAs, Why Is EVAR Better Than Open Repair: It Provides Better Short-Term Survival With No Long-Term Disadvantages: Technical Tips |
Presenter(s):Anders Wanhainen, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
INFECTED ARTERIAL GRAFTS AND ENDOGRAFTS | |
8:20 AM - 8:25 AM | With Infected Arterial Prosthetic Grafts, Graft Removal Is Not Always Necessary When And How Can They Be Treated Successfully Without Graft Removal: Technical Requirements |
Presenter(s):Samy S. Nitecki, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:26 AM - 8:31 AM | DEBATE: With Infected Arterial Grafts And Endografts, Removal Of The Graft Is Mandatory With Some Form Of Revascularization: How To Do It |
Presenter(s):Werner Lang, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:32 AM - 8:37 AM | DEBATE: Not So: Non-Excisional Treatment Is Better And Safer In Most Instances: How To Do It And Technical Requirements: When Must The Graft Be Removed |
Presenter(s):Martin Malina, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:38 AM - 8:43 AM | Value Of PET/CT Scans In Detecting And Treating Vascular Graft Infections: What Are Their Limitations |
Presenter(s):Zoran Rancic, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:44 AM - 8:49 AM | New Developments In The Treatment Of Aortic Prosthetic Graft Infection: Is The NAIS Procedure (Deep Vein Replacement) Really Better Than Other Methods: What May Be Better And How Does PET/CT Scanning Help In Treatment Planning |
Presenter(s):Patrick A. Stone, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
8:50 AM - 8:58 AM | Panel Discussion |
8:58 AM - 9:03 AM | Obturator Bypass Remains An Option For Revascularization With Multi-Operated Infected Groins: Tips And Tricks: However, There Are Other Options – What Are They |
Presenter(s):Frederic Cochennec, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:04 AM - 9:09 AM | Staging Classification For Treating Infected Arterial Prosthetic Grafts: When Can All Or A Portion Of An Infected Graft Be Left In Place: Technical Requirements |
Presenter(s):Russell H. Samson, MD, RVT, FACS / Keith D. Calligaro, MD / Frank J. Veith, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:10 AM - 9:15 AM | Value Of Antibiotic Polymethyl Methacrylate Beads In Treating Prosthetic Arterial Graft Infections: When Can Grafts In Infected Wounds Be Salvaged: Technical Tips And Requirements |
Presenter(s):Michael B. Silva, Jr., MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
SUPRARENAL AORTIC GRAFT AND ENDOGRAFT INFECTIONS | |
9:16 AM - 9:21 AM | Excision And Replacement Of Infected Suprarenal Open Or Endo Infected Grafts Is Feasible But Challenging: How To Do It |
Presenter(s):Thomas C. Bower, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:22 AM - 9:27 AM | Optimal Treatment Of Infected Aortic Grafts – Infrarenal And Suprarenal; Open And Endo |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:28 AM - 9:33 AM | New Developments And Long-Term Experience With The Treatment Of Infected AAAs And Aortic Endografts |
Presenter(s):Kamphol Laohapensang, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:34 AM - 9:39 AM | Optimal Treatment Of Aortobronchial And Aortoesophageal Fistulas After TEVAR: Both Are Challenging And Neither Is Hopeless: Technical Tips |
Presenter(s):Germano Melissano, MD / Roberto Chiesa, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
9:40 AM - 9:47 AM | Panel Discussion |
9:47 AM - 10:02 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 80 | |
SESSION 81 SCHEDULE | |
Friday
SESSION 81:
ADVANCES IN IMAGING AND HYBRID OPERATING/PROCEDURE ROOMS
|
|
x | |
10:02 AM - 10:07 AM | SFA And Popliteal Stenting Under Duplex Ultrasound Guidance: Tips And Tricks To Make It Work: It Is A Better Way And Decreases Radiation Exposure And Avoids Contrast Toxicity |
Presenter(s):Ignacio Escotto, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:08 AM - 10:13 AM | Why Incidental Findings On Vascular Imaging Are Increasing In Frequency And – Although Sometimes Helpful – Are More Frequently Harmful |
Presenter(s):Frank J. Criado, MD, FACS, FSVM Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:14 AM - 10:19 AM | How To Use CO2 To Image Tibial Arteries Safely And More Accurately Than With The Usual Contrast Agents |
Presenter(s):Palma M. Shaw, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:20 AM - 10:25 AM | Optical Coherence Tomography (OCT): How To Use It And How It Can Help In Decision Making With The Treatment Of Carotid Stenosis And During CAS |
Presenter(s):Francesco Setacci, MD / Carlo Setacci, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:26 AM - 10:31 AM | Why Is OCT A Better Imaging Modality Than IVUS For Lower Extremity Atherectomy And Treating Total Occlusions: What About Cost And How To Eliminate Blood From Blocking The Image |
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:32 AM - 10:37 AM | How To Use MRI And MRA For Planning And Fusion In The Treatment Of TAAAs: Advantages And Limitations |
Presenter(s):Martin J. Austermann, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:38 AM - 10:43 AM | Unique Value Of 3D Holographic Imaging In Complex Endovascular Procedures: How Does It Work: When Will It Be Available And What Does It Cost |
Presenter(s):Elchanan Bruckheimer, MBBS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:44 AM - 10:49 AM | Improvements In Any C-Arm Capability With Cloud Based 3D CT Fusion From Cyder Medical: Its Software Can Compensate For Changes In Anatomy By Stiff Wires And Devices: It Can Decrease Radiation Exposure And Contrast Usage |
Presenter(s):Cynthia K. Shortell, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:50 AM - 10:55 AM | Comparison Of Philips Vessel Navigator And Cydar Medical Fusion Systems: How They Work And Advantages, Limitations And Cost Of Each |
Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
10:56 AM - 11:01 AM | New Advances In Transcranial Doppler (TCD) And Its Value In Monitoring Carotid Procedures And Those Involving The Proximal Aorta And Arch: It Can Improve Results And Is An Underutilized And Under-Appreciated Technology |
Presenter(s):Zsolt Garami, MD / Alan B. Lumsden, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
11:02 AM - 11:07 AM | Future Advances In Hybrid Operating Suites: What Is On The Horizon And Beyond |
Presenter(s):Alan B. Lumsden, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
11:08 AM - 11:18 AM | Panel Discussion |
END OF SESSION 81 | |
SESSION 82 SCHEDULE | |
Friday
SESSION 82:
CHALLENGING RECORDED LIVE CASES FROM MÜNSTER
Location: Grand Ballroom West, 3rd Floor
Moderators:Giovanni Torsello, MD / Martin J. Austermann, MD |
|
x | |
11:18 AM - 12:00 PM | Complex Cases From Münster With Questions And Discussion |
Presenter(s):Giovanni Torsello, MD / Martin J. Austermann, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 82 | |
SESSION 83 SCHEDULE | |
Friday
SESSION 83:
CHALLENGING RECORDED LIVE CASES FROM THE MAYO CLINIC
Location: Grand Ballroom West, 3rd Floor
Moderators:Gustavo S. Oderich, MD, FACS / Bernardo C. Mendes, MD |
|
x | |
1:00 PM - 1:40 PM | Complex Cases From The Mayo Clinic With Questions And Discussion |
Presenter(s):Gustavo S. Oderich, MD, FACS / Bernardo C. Mendes, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
END OF SESSION 83 | |
SESSION 84 SCHEDULE | |
Friday
SESSION 84:
NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
|
|
x | |
1:40 PM - 1:45 PM | Current Fair Indications For Surgical Treatment Of Neurogenic TOS: Objective Outcome Measures To Determine Treatment Success |
Presenter(s):Karl A. Illig, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:46 PM - 1:51 PM | DEBATE: Transaxillary Approach Is The Best Way To Surgically Treat TOS: When Is It Not: How Can Video Assistance Be Helpful |
Presenter(s):Francesco Spinelli, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:52 PM - 1:57 PM | DEBATE: Not So: The Supraclavicular Approach Is Best For Surgical Treatment Of Most Patients With TOS: Technical Tips And When Is It Not |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
1:58 PM - 2:03 PM | Two New Developments In TOS: 1) A Paradigm Shift In Venous ToS Treatment: Open Decompression Combined With Selective Stenting Is The Way To Go; And 2) The Pectoralis Minor Syndrome Can Cause Recurrent Neurogenic TOS; How To Diagnose And Treat |
Presenter(s):Michael J. Singh, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
VENOUS TOS | |
2:04 PM - 2:09 PM | The Value Of Balloon Angioplasty For Venous TOS: When Is It Helpful And When Not: First Rib Removal Is Not Always Necessary: When Is It |
Presenter(s):Sam S. Ahn, MD, FACS, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:10 PM - 2:15 PM | Evolving Strategies For Treating Venous TOS: When Does It Need Surgical Treatment And When Not: Why The Infraclavicular Approach Is Best For Rib Resection And Allows Exposure Of The Subclavian Vein: Technical Tips |
Presenter(s):Keith D. Calligaro, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:16 PM - 2:21 PM | With Venous TOS And Subclavian Vein Thrombosis, For The Majority Of Patients, Thrombolytics Are Of No Benefit: How Should The Condition Be Treated |
Presenter(s):George Geroulakos, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:22 PM - 2:27 PM | Direct Oral Anticoagulant Treatment Versus Thrombolysis Plus First Rib Resection For Venous TOS With Subclavian Vein Thrombosis (Paget-Schrotter Syndrome): Are We Overtreating These Patients: From The UTOPIA Trial |
Presenter(s):Gert J. de Borst, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:28 PM - 2:34 PM | Panel Discussion |
END OF SESSION 84 | |
SESSION 85 SCHEDULE | |
Friday
SESSION 85:
IMPORTANT NEW DEVELOPMENTS IN MEDICAL AND ANTI-ATHEROGENIC AND ANTICOAGULANT DRUG TREATMENTS; UPDATES ON UNUSUAL DISEASES AND THEIR INTERVENTIONAL VASCULAR TREATMENT; MANAGEMENT OF TAVR ARTERIAL ACCESS COMPLICATIONS
|
|
x | |
2:34 PM - 2:39 PM | Statin Intolerance In Vascular Patients: Incidence, Management Techniques And Their Outcomes: From The VQI |
Presenter(s):Adam Beck, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:40 PM - 2:45 PM | Optimal Current Antiplatelet Treatment In Patients With Vascular Disease And After Interventional Or Open Treatment: When Is Aspirin Indicated And When Not |
Presenter(s):Roxana Mehran, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:46 PM - 2:51 PM | Value Of Protamine Use With Transfemoral CAS, TCAR And CEA: It Decreases Strokes And Postprocedural Bleeding |
Presenter(s):Marc L. Schermerhorn, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:52 PM - 2:57 PM | Why Clopidogrel Testing Is Important In CAS Trials And Other Vascular Trials |
Presenter(s):Karthikeshwar Kasirajan, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
2:58 PM - 3:03 PM | Why Vascular Surgeons And Specialists Should Replace Heparin With Bivalirudin For Vascular Interventions |
Presenter(s):George H. Meier, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:04 PM - 3:09 PM | Newer Oral Anticoagulants Are Not Helpful In Improving Outcomes After Lower Extremity Bypasses: However, Warfarin Is Helpful: What Is The Evidence |
Presenter(s):William P. Robinson, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:10 PM - 3:15 PM | Why EVAR Patients Must Be Given Statins Or Have Their Statin Dose Increased Perioperatively: Cardiac Complications Are The Main Cause Of Complications And Readmissions And Statins Decrease These |
Presenter(s):Bruce A. Perler, MD, MBA Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:16 PM - 3:22 PM | Panel Discussion |
Moderator(s): Ronald M. Fairman, MD / Roxana Mehran, MD | |
3:22 PM - 3:32 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
UPDATE ON ENDOVASCULAR TREATMENT OF MULTIPLE SCLEROSIS AND OTHER HOT TOPICS | |
3:32 PM - 3:37 PM | Is There Any Hope That There Will Be Evidence To Support The Value Of Venous Angioplasty To Treat Multiple Sclerosis – Despite Negative Level 1 Evidence |
Presenter(s):Paolo Zamboni, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:38 PM - 3:43 PM | What Is The Evidence That Venous Obstruction Contributes To Multiple Sclerosis And That Relieving This Obstruction Can Help Some Patients: Which Patients And How To Select Them |
Presenter(s):Donald B. Reid, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:44 PM - 3:49 PM | Biomarkers Can Predict Poor Outcomes Of Vascular Surgery: Which Biomarkers; Which Procedures |
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:50 PM - 3:55 PM | Natural History Of Penetrating Ulcers Of The Abdominal Aorta: How Should They Be Treated |
Presenter(s):Caron B. Rockman, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
3:56 PM - 4:01 PM | Natural History Of Common Iliac And Internal Iliac Artery Aneurysms: They Are Benign When ≤ 4 cm And Do Not Require Treatment Until >4 cm |
Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:02 PM - 4:07 PM | Current Endovascular Treatment Of Buerger’s Disease: What Is Possible And What Is Not |
Presenter(s):Kamphol Laohapensang, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:08 PM - 4:13 PM | Vascular Complications Of TAVR And How Are They Best Managed |
Presenter(s):Ashraf Mansour, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:14 PM - 4:20 PM | Panel Discussion |
END OF SESSION 85 | |
SESSION 86 SCHEDULE | |
Friday
SESSION 86:
NEW DEVELOPMENTS IN THE MANAGEMENT OF VASCULAR TRAUMA: PROS AND CONS OF REBOA; ENDO VERSUS OPEN TREATMENTS
Location: Grand Ballroom West, 3rd Floor
Moderators:Michael B. Silva, Jr., MD / Todd E. Rasmussen, MD, FACS |
|
x | |
4:20 PM - 4:25 PM | Why And How Vascular Surgeons Need To Take The Lead In Supporting Excellence In Trauma Management And Treatment Of Vascular Injuries: There Is No Valid Competition |
Presenter(s):Joseph J. DuBose, MD / Todd E. Rasmussen, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:26 PM - 4:31 PM | New Developments From An International Collaboration On Endovascular Techniques For Resuscitation And Trauma Management: The EVTM Group: What Is It And How Is It Helping Society, Patients And Doctors |
Presenter(s):Tal M. Hörer, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:32 PM - 4:37 PM | A Balanced View About REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta): What Is Good About It: And What Might Be Not So Good |
Presenter(s):Gilbert R. Upchurch, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:38 PM - 4:43 PM | REBOA Is A Double-Edged Sword: The SOROKA Experience From Israel |
Presenter(s):Gabriel Szendro, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:44 PM - 4:49 PM | Endovascular Access In Untrained Hands Can Fail: This Has Led To A Declining Use Of REBOA: How Can This Be Fixed |
Presenter(s):Charles J. Fox, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:50 PM - 4:55 PM | Endovascular Versus Open Surgery For Vascular Trauma: When Is Each Approach Necessary And Appropriate: How Is The Field Changing |
Presenter(s):James W. Dennis, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
4:56 PM - 5:01 PM | How Endovascular Procedures Are Saving Patients With Vascular Emergencies: Why Vascular Surgeons Need To Take Advantage Of Them And Incorporate Them In Their Practice |
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:02 PM - 5:08 PM | Panel Discussion |
BLUNT THORACIC AORTIC INJURIES (BTAIs) | |
5:08 PM - 5:13 PM | Long-Term (> 5 Years) Follow-Up Of TEVAR For BTAIs: It Is A Very Durable Procedure |
Presenter(s):Johnny Steuer, MD, PhD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:14 PM - 5:19 PM | Optimal Management Of Patients With BTAIs And Intracranial Bleeding: Timing Of Treatments, Use Of Heparin And Other Tips |
Presenter(s):Elina Quiroga, MD, MPH Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:20 PM - 5:25 PM | Shorter Than Usual Proximal Landing Zones For TEVAR Are Acceptable For BTAIs Because Aortas Are Usually Smaller And Healthier In These Patients: What Are The Limits And Technical Tips |
Presenter(s):Shang Loh, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:26 PM - 5:31 PM | In TEVAR For BTAIs It Is Safe To Cover The Left Subclavian Artery Without Revascularizing It If The Left Vertebral Artery Is Patent |
Presenter(s):Michael C. Stoner, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:32 PM - 5:37 PM | Treatment Priorities In Combined Orthopedic And Vascular Extremity Injuries: It Is Not Simple: Technical Tips |
Presenter(s):Markus K. Furrer, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:38 PM - 5:43 PM | Tips And Tricks For Damage Control In Vascular Surgery: Value Of Embolic Agents In Vascular Trauma: Which Is Best And Other Technical Tips |
Presenter(s):Ravi R. Rajani, MD Location: Grand Ballroom West, 3rd Floor |
|
View Slides in PDF | |
5:44 PM - 5:52 PM | Panel Discussion End of Program K |
END OF SESSION 86 | |
SESSION 87 SCHEDULE | |
Friday
SESSION 87:
PELVIC VENOUS DISORDERS, NUTCRACKER SYNDROME, CHRONIC VENOUS OCCLUSIONS, STRATEGIES TO DIAGNOSE AND INTERVENE
Location: Trianon Ballroom, 3rd Floor
Moderators:Jose I. Almeida, MD, FACS, RPVI, RVT / Lowell S. Kabnick, MD, RPhS, FACS, FACPh / Thomas W. Wakefield, MD / Kenneth Ouriel, MD, MBA |
|
x | |
7:00 AM - 7:04 AM | Introduction: Deep System |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh Location: Trianon Ballroom, 3rd Floor |
|
7:05 AM - 7:10 AM | ACCESS Trial Data From Chronic DVT: Role Of EKOS And TPA |
Presenter(s):Mark J. Garcia, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:11 AM - 7:16 AM | Venographic Techniques To Identify Pelvic Anatomy And Escape Points |
Presenter(s):Mark H. Meissner, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:17 AM - 7:22 AM | Pelvic Reflux: Is Coil Embolization The Answer |
Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:23 AM - 7:28 AM | Complications Of Renal Vein Stenting For Nutcracker Syndrome |
Presenter(s):Peter Gloviczki, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:29 AM - 7:34 AM | Open Surgery For Nutcracker: Techniques And Results |
Presenter(s):Cynthia K. Shortell, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:35 AM - 7:40 AM | Corrective Procedures For Failed Renal Vein Stenting |
Presenter(s):Peter Gloviczki, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:41 AM - 7:46 AM | Panel Discussion |
CHRONIC VENOUS OCCLUSIONS | |
Moderator(s): Peter Gloviczki, MD / Stephen A. Black, MD | |
7:47 AM - 7:52 AM | Anatomical And Clinical Variations In Patients With Post-Thrombotic Venous Outflow Obstruction |
Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:53 AM - 7:58 AM | A Good Stent Went Bad: What To Do |
Presenter(s):Gerard J. O'Sullivan, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
7:59 AM - 8:04 AM | Recanalizing Occluded Venous Stents |
Presenter(s):Akhilesh K. Sista, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:05 AM - 8:10 AM | Contralateral Deep Vein Thrombosis After Iliac Vein Stenting: A Clear And Present Danger |
Presenter(s):Peter Gloviczki, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:11 AM - 8:16 AM | Crossing Chronic Femoro-Iliocaval Occlusions With Cone Beam CT |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:17 AM - 8:22 AM | Endovenectomy And Iliac Vein Stent Placement - How I Do It (Video Technique Demonstration) |
Presenter(s):Houman Jalaie, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:23 AM - 8:28 AM | AbreTM Venous Self-Expanding Stent System Procedure Video |
Presenter(s):Stephen A. Black, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:29 AM - 8:34 AM | Challenging Deep Venous Recanalization: Go-To Tools And Approaches |
Presenter(s):Kush R. Desai, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:35 AM - 8:40 AM | Panel Discussion |
END OF SESSION 87 | |
SESSION 88 SCHEDULE | |
Friday
SESSION 88:
ILIOCAVAL STENTS, STENT TRIALS AND STENT SURVEILLANCE
Location: Trianon Ballroom, 3rd Floor
Moderators:Kenneth Ouriel, MD, MBA / Michael K.W. Lichtenberg, MD |
|
x | |
8:41 AM - 8:46 AM | Importance Of Stent Shape And Area On Clinical Outcome After Iliofemoral Venous Stenting (VICI Trial) |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:47 AM - 8:52 AM | Venovo Venous Stent Trial: Update |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:53 AM - 8:58 AM | Zilver/Vena Stent Trial: Update |
Presenter(s):Gerard J. O'Sullivan, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
8:59 AM - 9:04 AM | VICI Stent Trial Update: 2 Years |
Presenter(s):Mahmood Razavi, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:05 AM - 9:10 AM | Technical Properties Of Nitinol: The Role Of Venous Stenting |
Presenter(s):Erin H. Murphy, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:11 AM - 9:16 AM | What You Should Know About The 4 Dedicated Venous US Stents: European Experience |
Presenter(s):Michael K.W. Lichtenberg, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:17 AM - 9:22 AM | Use Of Biopsy Of Venous In-Stent Stenosis To Guide Post-Operative Management |
Presenter(s):David M. Williams, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:23 AM - 9:28 AM | Surveillance After Venous Stenting: How And When |
Presenter(s):Kenneth Ouriel, MD, MBA Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:29 AM - 9:34 AM | Panel Discussion |
END OF SESSION 88 | |
SESSION 89 SCHEDULE | |
Friday
SESSION 89:
MORE ON ILIOCAVAL STENTS, STENT PROBLEMS POST-IMPLANTATION, MEDICAL AND HYBRID TECHNIQUES TO REDUCE VENOUS HYPERTENSION
|
|
x | |
9:35 AM - 9:40 AM | A Novel Technique And Outcomes For Iliocaval Extravascular Reconstruction (TIER) For Iliocaval Agenesis |
Presenter(s):Steven D. Abramowitz, MD / Edward Y. Woo, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:41 AM - 9:46 AM | Neointima Formation Following Venous Placement Of Self-Expanding Nitinol-Stents Of Different Porosity: Clinical And Experimental Results |
Presenter(s):Houman Jalaie, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:47 AM - 9:52 AM | Predictors Of Failure Of Iliac Vein Stenting |
Presenter(s):Rabih A. Chaer, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:53 AM - 9:58 AM | New And Validated Classification Of Chronic Venous Obstruction And Its Clinical Implications |
Presenter(s):Houman Jalaie, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
9:59 AM - 10:04 AM | What Is The Optimal Anticoagulant/Antithrombotic Regimen For Patients Undergoing Iliac Vein Stent |
Presenter(s):Michael R. Jaff, DO Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:05 AM - 10:10 AM | Managing Anticoagulation To Avoid Postoperative Hemorrhage |
Presenter(s):Timothy K. Liem, MD, MBA Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:11 AM - 10:16 AM | Percutaneous, Open Or Hybrid Deep Venous System Surgery: Indications And Results |
Presenter(s):Ignacio Escotto, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:17 AM - 10:22 AM | Stent Extension Into A Single Inflow Vessel Is A Valuable Option After Endophlebectomy |
Presenter(s):Rick De Graaf, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:23 AM - 10:28 AM | Panel Discussion |
END OF SESSION 89 | |
SESSION 90 SCHEDULE | |
Friday
SESSION 90:
STRATEGIES FOR CORRECTING SEVERE DEEP VENOUS OBSTRUCTION, VENOUS ULCERS AND NEW HORIZONS IN WOUND CARE
|
|
x | |
10:29 AM - 10:34 AM | SSAT Trial: Single Session Angioplasty Thrombolysis For Chronic Infrainguinal Deep Disease |
Presenter(s):Steve Elias, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:35 AM - 10:40 AM | Venous Issues In Thoracic Outlet Syndrome: Lysis, Venoplasty, First Rib Resection: Staged Or Same Setting |
Presenter(s):Karl A. Illig, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:41 AM - 10:46 AM | When Venous Stents Are Not Enough |
Presenter(s):Marzia Lugli, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:47 AM - 10:52 AM | 90% Well-Recognized Venographic Signs Of Significant Iliac Vein Compression In Asymptomatic Young Volunteers |
Presenter(s):Cees H.A. Wittens, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:53 AM - 10:58 AM | Non-Invasive 24/7 Flow Augmentation In Deep Venous Pathology |
Presenter(s):Cees H.A. Wittens, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
10:59 AM - 11:04 AM | Panel Discussion |
VENOUS ULCERS AND NEW HORIZONS IN WOUND CARE | |
Moderator(s): William A. Marston, MD / Joseph D. Raffetto, MD | |
11:05 AM - 11:10 AM | The Use Of Skin Substitutes To Promote Venous Leg Ulcer Healing |
Presenter(s):Sarah Onida, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:11 AM - 11:16 AM | The Link Between Deep Vein Reflux And Non-Healing Ulcers, A Deep Vein Valve Is Sorely Needed |
Presenter(s):William A. Marston, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:17 AM - 11:22 AM | Different Biochemical Profiles In Inflammatory And Granulating Wounds |
Presenter(s):Joseph D. Raffetto, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:23 AM - 11:28 AM | The True Cost Of Managing Venous Leg Ulcers: An International Review |
Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:29 AM - 11:34 AM | Important RCTs For Venous Wound Healing |
Presenter(s):William A. Marston, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:35 AM - 11:40 AM | The Recalcitrant Venous Ulcer: An Analysis Of Factors In 22 Of 60 That Failed To Heal After A 52-Week Period Of Treatment In Our Wound Center |
Presenter(s):Thomas F. O'Donnell, Jr., MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:41 AM - 11:46 AM | Panel Discussion |
END OF SESSION 90 | |
SESSION 91 SCHEDULE | |
Friday
SESSION 91:
CAVAL RECONSTRUCTION AND MORE FEMORAL AND ILIOCAVAL FLOW ISSUES
Location: Trianon Ballroom, 3rd Floor
Moderators:R. Clement Darling III, MD / Jose I. Almeida, MD, FACS, RPVI, RVT |
|
x | |
11:47 AM - 11:52 AM | IVC Replacement For Malignancy: How I Do It |
Presenter(s):R. Clement Darling III, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:53 AM - 11:58 AM | Long-Term Patency Of Primary Inferior Vena Cava Reconstructions |
Presenter(s):Mark K. Eskandari, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
11:59 AM - 12:04 PM | Optimal PTS Prevention |
Presenter(s):Peter Henke, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
12:05 PM - 12:11 PM | Venous Stent Fractures: Does It Matter |
Presenter(s):David J. Dexter, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
12:12 PM - 12:17 PM | Stent Reconstruction Following IVC Filter-Related Caval Thrombosis |
Presenter(s):Akhilesh K. Sista, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
12:18 PM - 12:23 PM | Thrombosed IVC Filter: How To Recanalize The Cava And Manage The Filter |
Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
12:24 PM - 12:29 PM | Panel Discussion |
12:30 PM - 12:59 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd And 3rd Floors |
END OF SESSION 91 | |
SESSION 92 SCHEDULE | |
Friday
SESSION 92:
SURGICAL AND INTERVENTIONAL MANAGEMENT STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM
|
|
x | |
1:00 PM - 1:05 PM | Single Session Continuous Aspiration Thrombectomy (SSCAT) For All DVT Utilizing Indigo Thrombectomy System |
Presenter(s):Patrick E. Muck, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:06 PM - 1:11 PM | Inari CloTriever Device For Acute DVT |
Presenter(s):William A. Marston, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:12 PM - 1:17 PM | Thrombolysis For Acute DVT: Utilization And Guidance From Current Clinical Trials |
Presenter(s):Brian G. DeRubertis, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:18 PM - 1:23 PM | Sentry Two-Year Data |
Presenter(s):Robert Mendes, MD Location: Trianon Ballroom, 3rd Floor |
|
1:24 PM - 1:29 PM | A Comparison Of Angiojet Versus CDT For The Treatment Of Iliofemoral DVT |
Presenter(s):Stephen A. Black, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:30 PM - 1:35 PM | Subgroup Analyses Of The ATTRACT Trial |
Presenter(s):Suresh Vedantham, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:36 PM - 1:41 PM | Treating Venous Thromboembolism Without Lytic Medications |
Presenter(s):Constantino Pena, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:42 PM - 1:47 PM | Angiovac Venous Thrombectomy: Where, When, And How |
Presenter(s):Mikel Sadek, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:48 PM - 1:53 PM | Renal Failure In Acute DVT Treatment - Incidence And Strategies For Prevention |
Presenter(s):Stephen A. Black, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
1:54 PM - 1:59 PM | P-Max Study: Mechanical Thrombectomy For Iliofemoral DVT With Aspirex |
Presenter(s):Michael K.W. Lichtenberg, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:00 PM - 2:05 PM | Interventional Treatment Of Iliofemoral And Caval DVT In The Office Based Lab |
Presenter(s):Mark J. Garcia, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:06 PM - 2:11 PM | Treatment Of Chronic Deep Venous Occlusions: Patient Selection, Procedural Pearls |
Presenter(s):Kush R. Desai, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:12 PM - 2:17 PM | Outcome Of Venous Stents In Adolescents, Teenagers, And Pregnancy |
Presenter(s):Gerard J. O'Sullivan, MD / Mahmood Razavi, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:18 PM - 2:23 PM | May-Thurner Syndrome: From Board Question To Epidemic |
Presenter(s):Clifford M. Sales, MD, MBA, FACS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:24 PM - 2:29 PM | Pressure Measurements And IVUS In Deep Venous Obstructions, Mandatory Or Fancy |
Presenter(s):Rick De Graaf, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:30 PM - 2:35 PM | Is An Open Popliteal Vein A Prerequisite For Success: Does PMT Now Lead To Over-Stenting |
Presenter(s):Stephen A. Black, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:36 PM - 2:41 PM | How Important Is Rapid Flow Restoration In DVT |
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:42 PM - 2:47 PM | Panel Discussion |
END OF SESSION 92 | |
SESSION 93 SCHEDULE | |
Friday
SESSION 93:
MEDICAL MANAGEMENT STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM I
|
|
x | |
2:48 PM - 2:53 PM | The Open Vessel Hypothesis: Applicability To DVT |
Presenter(s):Kenneth Ouriel, MD, MBA Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
2:54 PM - 2:59 PM | Inflammation And Venous Thrombosis – An Evidence Summary |
Presenter(s):Thomas W. Wakefield, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:00 PM - 3:05 PM | Should All Patients With Acute VTE Be Treated With A Statin |
Presenter(s):Anthony J. Comerota, MD, FACS, FACC Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:06 PM - 3:11 PM | Update On Reversal Agents For The DOAC |
Presenter(s):Timothy K. Liem, MD, MBA Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:12 PM - 3:17 PM | Thrombus Aging Using MRI |
Presenter(s):Stephen A. Black, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:18 PM - 3:23 PM | What Is The Optimal Anticoagulant/Antithrombotic Regimen For Patients Undergoing Iliac Vein Stent |
Presenter(s):Michael R. Jaff, DO Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:24 PM - 3:29 PM | E-Selectin Inhibition Is Effective To Treat Proximal DVT In A Primate Model |
Presenter(s):Thomas W. Wakefield, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:30 PM - 3:35 PM | Panel Discussion |
MEDICAL MANAGEMENT STRATEGIES FOR THROMBOEMBOLIC EVENTS IN THE VENOUS SYSTEM II | |
Moderator(s): Peter Henke, MD / Alberto C. Duque, MD | |
3:36 PM - 3:41 PM | Breakthrough DVT: When Thromboprophylaxis Is Not Enough |
Presenter(s):Andrea T. Obi, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:42 PM - 3:47 PM | Pediatric DVT – An Evidence Summary |
Presenter(s):Dawn M. Coleman, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:48 PM - 3:53 PM | Provoked Or Unprovoked DVT - Does It Matter Therapeutically |
Presenter(s):Peter Henke, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
3:54 PM - 3:59 PM | Heparin Resistance During Thrombolysis For DVT |
Presenter(s):Jinsong Wang, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:00 PM - 4:05 PM | MIST Therapy In Warfarin Necrosis |
Presenter(s):Joann Lohr, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:06 PM - 4:11 PM | Introduction: Chinese DVT Database |
Presenter(s):Jinsong Wang, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:12 PM - 4:17 PM | Is Bridging Anticoagulation With The Direct Oral Anticoagulants Necessary |
Presenter(s):Alberto C. Duque, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:18 PM - 4:23 PM | Panel Discussion |
END OF SESSION 93 | |
SESSION 94 SCHEDULE | |
Friday
SESSION 94:
DEEP VEIN VALVE TECHNOLOGIES, CAVAL INTERRUPTION AND IVC FILTER COMPLICATIONS
|
|
x | |
DEEP VALVE PROGRESS | |
4:24 PM - 4:29 PM | Safety And Efficacy Report On The Blueleaf Endovenous Valve Formation System Update On International And US Clinical Progress |
Presenter(s):Mikel Sadek, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:30 PM - 4:35 PM | Safety And Efficacy Report On The Venovalve (First In Man) |
Presenter(s):Jorge H. Ulloa, MD, FACS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:36 PM - 4:41 PM | What Are The Challenges In The Deep System - What Is The Role Of Venous Valves |
Presenter(s):Fedor Lurie, MD, PhD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:42 PM - 4:47 PM | What’s Up With The Sail Valve |
Presenter(s):Steve Elias, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:48 PM - 4:53 PM | Surgical Creation Of A Monocusp Valve |
Presenter(s):Marzia Lugli, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
4:54 PM - 4:59 PM | Surgical Creation Of “Rival |
Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:00 PM - 5:05 PM | Internal Compression Treatment Application For Deep Venous Insufficiency: 1.5-Year Clinical Results |
Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh / Erdinc Eroglu, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:06 PM - 5:11 PM | Panel Discussion |
CAVAL INTERRUPTION AND IVC FILTER COMPLICATIONS | |
Moderator(s): Timothy K. Liem, MD, MBA / Constantino Pena, MD | |
5:12 PM - 5:17 PM | The Novate Sentry Trial With A Novel Bio-Convertible IVC Filter: Follow-Up At 2 Years |
Presenter(s):Robert Mendes, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:18 PM - 5:23 PM | Surgical Removal Of Perforated IVC Filters |
Presenter(s):Timothy K. Liem, MD, MBA Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:24 PM - 5:29 PM | Avoiding And Managing IVC Disruption During Difficult IVC Filter Removal |
Presenter(s):Brian G. DeRubertis, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:30 PM - 5:35 PM | Outcomes And Associated Factors In Malpractice Litigation Involving IVC Filters |
Presenter(s):Anil P. Hingorani, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:36 PM - 5:41 PM | The PREPIC Trial: Fact Or Fiction |
Presenter(s):John E. Rectenwald, MD, MS Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:42 PM - 5:47 PM | Why Temporary Filters Are Not Removed: Clinical Predictors In 1,000 Consecutive Cases |
Presenter(s):Heron E. Rodriguez, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:48 PM - 5:53 PM | What To Do With Fractured Filters And Embolic Filter Fragments |
Presenter(s):Constantino Pena, MD Location: Trianon Ballroom, 3rd Floor |
|
View Slides in PDF | |
5:54 PM - 6:00 PM | Panel Discussion End of Program L |
END OF SESSION 94 |